Mia Thagesson

The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation

Anne Månsson Kvarnhammar, Niina Veitonmäki, Karin Hägerbrand et al. · Journal for ImmunoTherapy of Cancer · 2019 · 110 citations · Full text

Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies

Karin Hägerbrand, Laura A. Varas, Adnan Deronic et al. · Journal for ImmunoTherapy of Cancer · 2022 · 25 citations · Full text

The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo

Adnan Deronic, Anneli Nilsson, Mia Thagesson et al. · Cancer Immunology Immunotherapy · 2021 · 18 citations · Full text